PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
01-Apr-2020 Hikma confirms favourable ruling in generic Vascepa® patent suit Hikma
01-Apr-2020 Bayer receives authorisation in Europe for NUBEQA®▼(darolutamide), a new treatment for men with non-metastatic castration-resistant prostate cancer Bayer
01-Apr-2020 Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Malignant Mesothelioma in China Chi-Med
01-Apr-2020 2015: We appeared in the Sunday Times Fast Track Award as one of the 200 fastest growing Companies in the UK for sales. We finished 78th out of 200 Sense Biodetection Limited
01-Apr-2020 EUSA PHARMA AND PAPA GIOVANNI XXIII HOSPITAL, ITALY, PROVIDE INTERIM ANALYSIS DATA FOR SILTUXIMAB-TREATED COVID-19 PATIENTS FROM THE SISCO STUDY EUSA PHARMA
01-Apr-2020 Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation Kiniksa
01-Apr-2020 GILEAD SCIENCES ANNOUNCES TWO PHASE 3 RANDOMISED STUDIES TO EVALUATE THE SAFETY AND ANTIVIRAL ACTIVITY OF REMDESIVIR (GS-5734™) IN PARTICIPANTS WITH MODERATE TO SEVERE COVID-19 Gilead
31-Mar-2020 Accord donates two million tablets of hydroxychloroquine to largest COVID-19 trial in the world involving 40,000 frontline healthcare workers Accord Healthcare
30-Mar-2020 Brilinta Monotherapy Shown to Reduce Bleeding in High-Risk Patients AstraZeneca
30-Mar-2020 Imfinzi approved in the US for extensive-stage small cell lung cancer AstraZeneca
30-Mar-2020 Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic Abeona Therapeutics
30-Mar-2020 LATEST ACC DATA: Phase III Forxiga DAPA-HF Trial Sub-analysis shows consistent effect regardless of background therapy AstraZeneca
30-Mar-2020 Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 Sanofi
30-Mar-2020 Faron Pharmaceuticals Oy: Completion of Part 1 dose finding stage of the MATINS Phase I/II Study Faron Pharmaceuticals Ltd
30-Mar-2020 Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program Ergomed plc
30-Mar-2020 ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology ImaginAb Inc
30-Mar-2020 Envision Pharma Group ranked in Top 10 of the fastest-growing UK companies in pharma Envision Pharma Group
27-Mar-2020 Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma Sanofi
27-Mar-2020 LifeArc launches £10 million research fund to address the challenges of COVID-19 LifeArc
27-Mar-2020 Board Changes NMC Health plc